Status:
NOT_YET_RECRUITING
SUNRISE Aims to Create a Comprehensive, Engaging, and Sustainable Digital Health Promotion Program That Not Only Addresses Immediate Health Behaviours But Also Instils Lifelong Healthy Habits Among Adolescents. It is a Unique, Digitally Enhanced Program Combining Different Digital Solutions With New
Lead Sponsor:
Biocruces Bizkaia Health Research Institute
Collaborating Sponsors:
FEDERAZIONE ITALIANA DELLE ASSOCIAZIONI DI VOLONTARIATO IN ONCOLOGIA
Hellenic Mediterranean University
Conditions:
Cancer
Eligibility:
All Genders
10-19 years
Brief Summary
SUNRISE aims to create a comprehensive, engaging, and sustainable digital health promotion program that not only addresses immediate health behaviours but also instills lifelong healthy habits among a...
Detailed Description
Cancer remains one of the leading causes of death globally, with significant potential for prevention through early adoption of healthy behaviours. Adolescence is a crucial period for establishing suc...
Eligibility Criteria
Inclusion
- Minimum Age: Students must be at least 10 years old at the time of enrolment.
- Devices and Internet Access: Students must have access to an electronic device with Internet connectivity.
- Informed Consent: Students must provide their signed informed consent to participate in the study.
- Parental Consent: Students, when necessary, must obtain and submit signed informed consent from a parent or legal guardian.
Exclusion
- Age Restrictions: Students who are younger than 10 years or older than the established age range for participation.
- Consent Issues: Students who have not signed the informed consent form or do not have signed informed consent from their parents or legal guardians.
- Follow-up Limitations: Students who are unable to commit to the follow-up period of at least 18 months or are unlikely to complete the study.
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2028
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT06931847
Start Date
September 1 2025
End Date
April 1 2028
Last Update
April 17 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Ghent University (UGENT)
Zürich, Belgium, 9000
2
Cyprus Association of Cancer Patients and Friends (PASYKAF)
Nicosia, Cyprus, 1687
3
Hellenic Mediterranean University (HMU)
Heraklion, Greece, 71410
4
Italian Federation of Voluntary Associations in Oncology (FAVO)
Roma, Italy, 00187